Derbel Miled, Olfa <br/><br/>
Sorafenib and sunitinib for elderly patients with renal cell carcinoma.  [electronic resource] 

 -  Journal of geriatric oncology  Jul 2013 
 - 255-61 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1879-4076 
<br/><br/><label>Standard No.: </label>10.1016/j.jgo.2013.04.004  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Aged, 80 and over<br/>Antineoplastic Agents--therapeutic use<br/>Asthenia--chemically induced<br/>Carcinoma, Renal Cell--drug therapy<br/>Disease-Free Survival<br/>Drug Eruptions--etiology<br/>Female<br/>Humans<br/>Indoles--therapeutic use<br/>Kidney Neoplasms--drug therapy<br/>Male<br/>Neutropenia--chemically induced<br/>Niacinamide--analogs & derivatives<br/>Phenylurea Compounds--therapeutic use<br/>Pyrroles--therapeutic use<br/>Retrospective Studies<br/>Sorafenib<br/>Sunitinib<br/>Treatment Outcome